1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029 : A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy
(
- Contribution to journal › Letter
- 2021
-
Mark
A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer
(
- Contribution to journal › Article
-
Mark
Urinary diversions for benign and oncologic indications: what did we learn about short term complications in the last 24 months?
(
- Contribution to journal › Article
- 2018
-
Mark
High risk of hypogonadism in young male cancer survivors
(
- Contribution to journal › Article
- 2017
-
Mark
Risk of low bone mineral density in testicular germ cell cancer survivors : Association with hypogonadism and treatment modality
(
- Contribution to journal › Article
-
Mark
Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome
(
- Contribution to journal › Article